Download presentation
Presentation is loading. Please wait.
Published byValentijn Smeets Modified over 5 years ago
1
The Zollinger–Ellison Syndrome: Dangers and Consequences of Interrupting Antisecretory Treatment
Pierre Poitras, Marie–Hélène Gingras, Jens F. Rehfeld Clinical Gastroenterology and Hepatology Volume 10, Issue 2, Pages (February 2012) DOI: /j.cgh Copyright © 2012 AGA Institute Terms and Conditions
2
Figure 1 Barium swallow of the esophagus with multiple strictures of the lumen in a patient (patient 1 in this study) who suffered profuse vomiting of gastric acid at the interruption of PPI treatment. Clinical Gastroenterology and Hepatology , DOI: ( /j.cgh ) Copyright © 2012 AGA Institute Terms and Conditions
3
Figure 2 Diagnostic evaluation of ZES. AB, antibody; BAO, basal acid output (mmol/h); EUS, endoscopic ultrasound; MRI, magnetic resonance imaging; PA, pernicious anemia. Clinical Gastroenterology and Hepatology , DOI: ( /j.cgh ) Copyright © 2012 AGA Institute Terms and Conditions
Similar presentations
© 2024 SlidePlayer.com. Inc.
All rights reserved.